Rajavelu Esther
SEC CIK 1903716 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | See Remarks | 986.9K | — | $476.0K | 11 | 2023-11-13 | 2026-05-04 |
Most active insiders at SPRO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rajavelu Esther | See Remarks | — | $406.8K |
| 2 | Keutzer Timothy | COO | — | $145.2K |
| 3 | Tregoning Kathleen | Dir | — | — |
| 4 | Zack Debra | Chief Medical Off | — | — |
| 5 | Smith Cynthia | Dir | — | — |
| 6 | Jackson Scott Thomas | Dir | — | — |
| 7 | VINK PATRICK V.J.J. | Dir | — | — |
| 8 | Deshpande Milind | Dir | — | — |
| 9 | Pottage John C Jr | Dir | — | — |
| 10 | THOMAS FRANK E | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-06 21:53 | 2026-05-04 | SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | See Remarks | S - Sale | $2.51 | -25.2K | 986.9K | -2% | -$63.4K | |
| M | 2026-02-09 | 2026-02-06 | SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | See Remarks | S - Sale | $2.36 | -87.9K | 1.01M | -8% | -$207.5K |
| D | 2026-02-04 | 2026-02-02 | SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | See Remarks | S - Sale | $2.20 | -18.4K | 1.10M | -2% | -$40.6K |
| D | 2026-02-04 | 2026-02-02 | SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | See Remarks | A - Grant | $0.00 | +249.0K | 1.12M | +29% | $0 |
| 2025-11-12 | 2025-11-07 | SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | See Remarks | S - Sale | $2.37 | -40.3K | 869.5K | -4% | -$95.4K | |
| 2025-05-06 | 2025-05-02 | SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | See Remarks | A - Grant | $0.00 | +185.0K | 909.7K | +26% | $0 | |
| 2025-02-05 | 2025-02-05 | SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | CFO, CBO | S - Sale | $0.78 | -20.7K | 724.7K | -3% | -$16.1K | |
| M | 2025-02-05 | 2025-02-03 | SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | CFO, CBO | A - Grant | $0.00 | +366.1K | 645.4K | +131% | $0 |
| M | 2024-11-12 | 2024-11-07+ | SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | CFO, CBO | S - Sale | $1.31 | -40.6K | 396.5K | -9% | -$53.0K |
| 2024-02-05 | 2024-02-01 | SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | See Remarks | A - Grant | $0.00 | +119.9K | 419.9K | +40% | $0 | |
| 2023-11-15 | 2023-11-13 | SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | See Remarks | A - Grant | $0.00 | +300.0K | 300.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations